Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Phasebio Pharmaceuticals Inc.
Headquarters: Malvern, PA, United States of America
Website: N/A
Year Founded: 2002
Status: Out of Business
BioCentury | Apr 12, 2024
Management Tracks
Disagreement over Biosecure Act pushed Shipley out of BIO
Plus: Melita Sun Jung named CBO at Terns, and updates from Zentalis, Pharvaris, Nuevocor and Stalicla
BioCentury | Jul 21, 2023
Management Tracks
Ann Lee-Karlon named CEO of EpiBiologics
Plus: Haas becomes CEO at LimmaTech, and updates from Sagimet, Agenus, Triumvira and Passage Bio
BioCentury | Jun 21, 2023
Management Tracks
Jonathan Mow named CEO at Veralox
Plus: Ottesen becomes CMO at Adcendo, and updates from Splice Bio, Shape, C4 and more
BioCentury | May 13, 2023
Deals
May 12 Quick Takes: AZ latest pharma to gain rights to a LaNova ADC
Plus: FDA clears Astellas’ therapy for hot flashes updates from Cullgen and SFJ-Serb
BioCentury | Apr 5, 2023
Data Byte
The market cap performance of the 2018 class of U.S. IPOs
At year-end, twice as many of the companies had lost value since their IPOs than gained value
BioCentury | Mar 31, 2023
Management Tracks
Amarin CEO Mikhail resigns, Kostas named chair
Plus: BioCryst appoints Hutson chair and updates from Flare, Mytide and TScan
BioCentury | Jan 18, 2023
Management Tracks
AZ’s Marshall becomes CEO of Juvenescence
Plus: Gomez retires as CEO from Siga, and updates from Full-Life, Remix, Sanotize and more
BioCentury | Nov 19, 2021
Management Tracks
Zhang becomes CSO at Aspen
Plus: PhaseBio, LifeSprout, Rejuveron and Aerami
BioCentury | Nov 16, 2021
Product Development
Nov. 15 Quick Takes: $500M first close of CBC’s biotech facilities venture
Plus PhaseBio, Rhythm, PharmaEssentia and more
Items per page:
1 - 10 of 45